Dr Roger Wu has over 20 years’ experience in the pharmaceuticals industry and was appointed as Chief Operating Officer of Consilient Health in January 2020.  He is responsible for leading the overall operational needs of the company and delivering the business strategy through Supply Chain, Quality Assurance, Regulatory Affairs and Technical Projects.

Prior to joining Consilient Health, Roger led many teams across multiple disciplines, including product development and project management in large pharmaceutical companies such as GSK and technical operations in generic pharmaceutical companies such as AMCo (now Advanz Pharma).

Roger holds a PhD from University of East Anglia in Pharmaceutical Sciences and an Executive MBA from Imperial College London.